Concepedia

Author

Jenny Devenport

Roche (Switzerland)ORCID

Also Known As

J. Devenport, Jacob M van Laar, Jenny Devenport, Jenny N Devenport, Jenny N. Devenport, M. Genovese

38

Publications

1.1K

Citations

15

H-Index

9

Concepts

All Affiliations

Roche (Switzerland)Hospital Universitario La PazMedical University of South CarolinaKings County Hospital CenterUniversity of Pennsylvania
JD

About

Jenny Devenport is an author at Roche (Switzerland) specializing in medicine, age-related diseases, and glaucoma.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

2

2

146

2

Orthopaedics

1

1

37

3

Rheumatology

1

1

37

4

Rheumatic Diseases

1

1

37

5

Age-related Diseases

1

1

109

Jenny Devenport

×

17

Publications

1K

Citations

15

H-Index

YearCitations

Effect of Alteplase vs Aspirin on Functional Outcome for Patients With Acute Ischemic Stroke and Minor Nondisabling Neurologic Deficits

Pooja Khatri, Dawn Kleindorfer, Thomas Devlin,

JAMA

2018

373

LAST II: Differential temporal responses of macular pigment optical density in patients with atrophic age-related macular degeneration to dietary supplementation with xanthophylls

Stuart Richer, Jenny Devenport, John C. Lang

Optometry

2007

109

Improvements in health-related quality of life after treatment with tocilizumab in patients with rheumatoid arthritis refractory to tumour necrosis factor inhibitors: results from the 24-week randomized controlled RADIATE study

V Strand, Gerd‐Rüdiger Burmester, Sarika Ogale,

Lara D. Veeken

2012

102

Tocilizumab as monotherapy or in combination with nonbiologic disease‐modifying antirheumatic drugs: Twenty‐four–week results of an open‐label, clinical practice study

Michael E. Weinblatt, Joel Kremer, John J. Cush,

Arthritis Care & Research

2012

62

Relationship Between Baseline and Early Changes in C‐Reactive Protein and Interleukin‐6 Levels and Clinical Response to Tocilizumab in Rheumatoid Arthritis

Jianmei Wang, Jenny Devenport, Jason M. Low,

Arthritis Care & Research

2015

50

Surgical Experience in Two Multicenter, Open-Label Phase 3 Studies of Emicizumab in Persons with Hemophilia A with Inhibitors (HAVEN 1 and HAVEN 2)

Rebecca Kruse‐Jarres, Michael U. Callaghan, Stacy E. Croteau,

Blood

2017

50

The effects of tocilizumab on osteitis, synovitis and erosion progression in rheumatoid arthritis: results from the ACT-RAY MRI substudy

Philip G. Conaghan, Charles Peterfy, Ewa Olech,

Annals of the Rheumatic Diseases

2014

47

The Effects of Splinting on Outcomes for Epicondylitis

V. Jane Derebery, Jenny Devenport, Geneva M. Giang,

Archives of Physical Medicine and Rehabilitation

2005

37

Exploring Concordance of Patient-Reported Information on PatientsLikeMe and Medical Claims Data at the Patient Level

Gabriel S. Eichler, Elisenda Cochin, Jian Han,

Journal of Medical Internet Research

2016

36

Interpreting the multi-biomarker disease activity score in the context of tocilizumab treatment for patients with rheumatoid arthritis

William Reiss, Jenny Devenport, Jason M. Low,

Rheumatology International

2015

24

Page 1